Today's Veterinary Business

AUG 2018

Today’s Veterinary Business provides information and resources designed to help veterinarians and office management improve the financial performance of their practices, allowing them to increase the level of patient care and client service.

Contents of this Issue

Navigation

Page 41 of 75

34 Today's Veterinary Business Business
Vetalytix is the industry's largest repository of localized economic insight,
regulatory compliance and pharmacy support tools, all of which are
designed to help the private practitioner compete in today's challenging
economy. Vetalytix is an open community available as a resource to the
veterinary profession and is sponsored by the NAVC, Today's Veterinary
Business and leading animal health distributors. For more detailed infor-
mation related to your local market, go to www.vetalytix.com.
Canine and feline core vaccine volumes, which were both mildly nega-
tive compared to the prior year, showed above-average growth during the
spring months. Canine influenza dose utilization increased when compared
to the prior year, consistent to the broader adoption of the antigen as a
critical component of vaccination protocols.
Procedural volume and flea and tick dose volume were both off from
the second quarter of 2017, but not significantly less impacted than the
effects observed nationally.
Mountain
For the second quarter in a row, overall veterinary business metrics for the
Mountain states were positive compared to broader national trends.
Overall clinical volume was up almost 6 percent compared to the sec-
ond quarter of 2017, double the growth rate observed on a national scale.
Canine and feline core vaccine volumes were both positive. Canine
core doses were up 7.4 percent compared to second-quarter 2017 values
and feline doses showed positive growth at almost 5 percent.
Canine influenza volume continued to show tremendous growth, far
outpacing the national averages.
Procedural volume, although negative, was less impacted than other
areas of the country compared to the second-quarter of 2017.
Flea and tick dose volume recovered significantly during the second
quarter, up almost 15 percent compared to the same period in 2017.
Pacific
In the second quarter of 2018, the Pacific states continued to observe posi-
tive business metrics compared to other parts of the country.
Overall clinical volume was up almost 4 percent compared to the first
quarter of 2017, still outpacing the national average but slightly lower than
the 4.8 percent growth observed in the first quarter of 2018.
Canine and feline core vaccine volumes, both relatively ahead of the
first-quarter broader market, appeared to have slowed somewhat in the
second quarter, with canine core volumes down 2.2 percent and feline core
volumes slightly positive at 1.7 percent.
Canine influenza utilization appears to still be exploding, up signifi-
cantly from the second quarter of 2017 and far outpacing adoption rates
on a national scale.
Procedural volume, although negative, was less impacted than other
areas of the country compared to 2017.
Flea and tick dose volume remained off from the second quarter of
2017, but not as impacted as the effects observed nationally.
Summary
For the second quarter in a row, data reveals that the markets and market
dynamics for veterinary medicine are very different depending on the part
of the country you're in. As a result, veterinary practices and the challenges
they face are just as diverse.
Data from the second quarter of 2018 suggests better overall market
conditions for veterinary practices compared to the tepid start observed in
the first quarter. Some categories, such as overall clinical volume, appear to
show marked improvements across the board compared to the disappoint-
ing first-quarter results seen in many regions. Other categories, such as flea
and tick dose volumes, continued to show challenges in the second quar-
ter, suggesting broader issues might be impacting the veterinary practice
as a channel.
But there's no doubt that some areas have significantly more chal-
lenges to face while others have positive dynamics to build off of for the
remainder of 2018. Understanding these dynamics and the role they play
in your market can provide insight into better meeting the needs of your
patients and clients.
East North Central (Great Lakes) Q2 2018 Q2 2018 National
Vet Consumption Index (Overall Clinical Volume) 2% 3%
Canine Core Vacc Doses 2.6% 1.6%
Canine Flu Vacc Doses 9.2% -18.6%
Feline Core Vacc Doses 6.3% 3.3%
Advanced Procedural Volume (Inhalant Anesth. Dynamics) -16.2% -14.7%
Flea Tick Doses -8.6% -8.3%
Mountain Q2 2018 Q2 2018 National
Vet Consumption Index (Overall Clinical Volume) 6% 3%
Canine Core Vacc Doses 7.4% 1.6%
Canine Flu Vacc Doses 114.2% -18.6%
Feline Core Vacc Doses 4.8% 3.3%
Advanced Procedural Volume (Inhalant Anesth. Dynamics) -10.2% -14.7%
Flea Tick Doses 14.7% -8.3%
Pacific Q2 2018 Q2 2018 National
Vet Consumption Index (Overall Clinical Volume) 4% 3%
Canine Core Vacc Doses -2.2% 1.6%
Canine Flu Vacc Doses 197.3% -18.6%
Feline Core Vacc Doses 1.7% 3.3%
Advanced Procedural Volume (Inhalant Anesth. Dynamics) -8.5% -14.7%
Flea Tick Doses -0.6% -8.3%
WEST MIDWEST NORTHEAST
Pacific Mountain
West
North Central
East
North Central
Middle
Atlantic
New
England
West
South Central
East
South Central
South
Atlantic
SOUTH
Source: U.S. Census Bureau
Business
THE VETALYTIX REPORT